Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell immunoglobulin mucin domain-containing protein 1 (TIM-1), also known as HAVCR1, is a type I transmembrane glycoprotein involved in immune regulation and various pathological processes. It acts as a stimulatory molecule for T-cell activation, particularly promoting Th2 responses. Overexpression of TIM‑1 has been observed across multiple tumor types, promoting tumor cell proliferation and resistance to apoptosis. It also functions as a cellular receptor for hepatitis A virus infection and serves as a biomarker for kidney damage under the name KIM‑1.
Inhibition of TIM-1 promotes cancer growth inhibition in preclinical models
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell immunoglobulin mucin domain-containing protein 1 (TIM-1).